Выбор темы
Выбор стиля шрифта
Ionis Pharmaceuticals новости
20/07
IONS - Сделка Инсайдера: продажа 15 июля 2022
26/04
IONS - Сделка Инсайдера: продажа 21 апреля 2022
15/04
IONS - Сделка Инсайдера: продажа 12 апреля 2022
06/04
IONS - Сделка Инсайдера: продажа 01 апреля 2022
01/02
🔗
Zacks Investment Research: Pfizer (PFE) Ends Vupanorsen Development, Returns Rights to Ionis
01/02
🔗
Benzinga: BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?
31/01
🔗
Market Watch: Ionis, Pfizer scrap plans for experimental cardiovascular drug
25/01
🔗
Zacks Investment Research: Ionis' (IONS) Eplontersen Gets Orphan Drug Tag From FDA
18/01
🔗
Zacks Investment Research: Ionis' (IONS) Partner to Begin New Huntington's Disease Study
05/01
🔗
PRNewsWire: Ionis to present at 40th Annual J.P. Morgan Healthcare conference
30/12
🔗
Zacks Investment Research: AstraZeneca (AZN) Closes Agreement for Eplontersen With Ionis
30/12
🔗
Zacks Investment Research: AstraZeneca (AZN) Closes Agreement for Eplontersen With Ionis
16/12
🔗
Seeking Alpha: Ionis Has A Lot Of Upside, I Am Bullish On This Stock
08/12
🔗
Zacks Investment Research: Ionis (IONS) Collaborates With AstraZeneca for Eplontersen
07/12
🔗
Pulse2: Ionis Pharmaceuticals Stock (IONS): Why The Price Jumped
02/12
🔗
Forbes: What's Happening With Ionis Pharmaceuticals Stock?
Загрузить еще